← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2011Last known activity
Apr 5, 2021
Timeline
2010s
- Jan 1, 2011
Cooper Human Systems— Founded
Drugs by trial phase (20 distinct, 9 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT04865211Lead sponsorPhase 2Apr 5, 2021
- NCT04552886Lead sponsorPhase 1Nov 1, 2020
- NCT04596657Lead sponsorN/AOct 27, 2020
- NCT04415918Lead sponsorPhase 4Jul 1, 2020
- NCT03973957Overall official - principal investigatorN/AMay 27, 2019
- NCT03973957Lead sponsorN/AMay 27, 2019
- NCT03973957Reponsible party - principal investigatorN/AMay 27, 2019
- NCT03906617Reponsible party - principal investigatorPhase 4Apr 10, 2019
- NCT03906617Lead sponsorPhase 4Apr 10, 2019
- NCT03996148Lead sponsorPhase 4Sep 29, 2017
- NCT03996148Reponsible party - principal investigatorPhase 4Sep 29, 2017
- NCT02475915CollaboratorPhase 1/Phase 2Jan 1, 2015
- NCT03914118Lead sponsorPhase 2Jan 1, 2008
- NCT03914118Reponsible party - principal investigatorPhase 2Jan 1, 2008
Details
- Founded
- Nashua, NH, US Jan 1, 2011
- Last known activity
- Apr 5, 2021